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The carcinogenicity of chemicals, both
synthetic and naturally occurring, provides
a subject of intense personal interest to the
general public. The public debate on these
issues is frequently confused by the in-
accurate assessment of experimental or
epidemiological data by people with little
experience in this field. The Monographs
provide outstanding examples of reliable
opinions on experimental and epidemiological
studies in this difficult area.
I. F. H. PURCHASE
An Introduction to Cell Population
Kinetics. W. A. AHERNE, R. S. CAMPLEJOHN
and N. A. WRIGHT (1977) London: E. Arnold
Ltd. 88 pp. £2.95 net.
In view of the fact that there are other
established textbooks on cell kinetics, some
ofwhich these authors recommend for further
reading, one might question the need for yet
another book on the subject. However, this
short presentation does fill a gap in the cell-
kinetic literature in 2 valuable ways. It
provides firstly, a useful basis to the various
cell-kinetic techniques that are now ex-
tensively used, outlining their strengths and
weaknesses, and secondly, in a relatively
simple and clear fashion, some valuable
statistical considerations.
The book has been well written and edited
with few typographical errors. It is somewhat
expensive for an 80-page paperback (about
3.5p per text page). My one major criticism
was the quality of the 3 photomicrographs.
This, I'm sure, was partly the consequence of
the printing process, but their quality and
clarity did not reach the standards ofthe rest
of the text. Consequently the mitoses in
Plate 1 are difficult to identify (arrows would
have helped). Plate 3 was equally difficult
for the uninitiated reader; labelled cells
could be seen with difficulty, even ifone knew
what to look for. Since the preface clearly
indicates that the book is designed to intro-
duce the reader to the subject, I think it is
unfortunate that the plates were not better. I
also found it somewhat surprising that the
book omitted reference to the original 1953
cell-cycle paper of Howard and Pelc.
The authors point out in the preface that
this is not a recipe book, but I feel that brief
recipes of the major techniques would have
been helpful to the type ofreader at whom the
book is directed.
I found that I had personal misgivings
about some of the statements and interpreta-
tions, particularly when some techniques are
applied to highly organized tissues which are
much more complex in terms of their cellular
heterogeneity than any cell-culture system.
However, the general content of the book
was good, and it should prove to be a useful
asset to research laboratories, particularly for
those beginning to work in the field. I found
the summaries at the end ofeach section very
helpful.
C. S. POTTEN
Immunocancerology in Solid Tumors Ed.
M. MARTIN and L. DIONNE (1976) New York:
Stratton Intercontinental Medical Book Corp.
182 pp. U.S.$17.95 net.
Thismonograph constitutes theproceedings
ofa Symposiumheld intheMedical Faculty of
of the University of Laval, Quebec, Canada.
The amount of new information disclosed is
of modest proportions, and the approach is
distinctly pro-clinical, and in many respects,
superficial.
A somewhat ambiguous tone is set by 2 of
the introductory articles. The first, by R. B.
Herberman, is a characteristically incisive
approach to the problem of human tumour
immunogenicity, in which the point is well
made that, even in animal model systems,
there is considerable complexity in the
debatable immune responses, and it is not at
all clear which ofthe antigens and correspond-
ing host reactions are really relevant in vivo.
The second, by G. M. Mavligit, still under the
heading of'Fundamental Concepts", is a more
opportunist approach, in which immunity to
human tumours is uncritically assumed and
its therapeutic exploitation almost a foregone
conclusion. However, this "fundamental" is
subsequently seen to be far from secure, and
whilst several tests are reported to be potenti-
ally useful in the "Immunological Work-up"
of the cancer patient, including leucocyte-
adherenceinhibition, migration inhibition and
CEA assays, few data are presented to indi-
catetheir actualusefulness in clinical practice.
Possibly, as Herberman again points out, such
assays mayultimately be ofvalue in combina-
tions, ifnot alone, in the monitoring or initial
diagnosis ofmalignant disease. Even so thereBOOK REVIEWS 651
is a greater need for more precise definition of
putative human tumour antigens. Exploita-
tion of such antigens in immunotherapy, on
the presumption that they exist, has yielded
only limited evidence of improved prognosis.
This is evident from the reviewr chapter by
Mastrangelo et al. on immunotherapeutic
studies on cancer patients. There is little
apparent cognizance of the dilemma which
faces the increasing number of clinicians
given to immunotherapeutic procedures, viz.
that a diversity of animal studies reveal that
immunotherapy has limited success, even
against the most antigenic of experimental
tumours. Indeed, it is somewhat ironic that
disappointing results in animals have not
prevented the widespread use of immuno-
therapy in man.
Other chapters are variously devoted to
macrophages and neoplasia (AMansell and
Diluzio) and anergy, anti-antibodies and
immune-complex disease (Terry et al.). Much
of the material presented has appeared else-
where, so that few will find this volume
essential.
M. MOORE
Review of Gastric and Colo-rectal
Cancers. (ConferenceReport) (1977) London:
MRC. 27 pp.
This Meeting reviewed the w%hole area of
malignant, disease ofthegastro-intestinal tract
in terms of instance, epidemiology, carcino-
genesis, diagnosis (including education) and
therapy. The details of the United States
Workshop (1977) on large-bowel cancer were
also reported.
From these items, various points are of
interest. The first is that 1 in 20 in the United
Kingdom die of carcinoma of the gastro-
intestinal tract. It was felt that more atten-
tion should be paid to the epidemiology ofthis
group of diseases, and in practical terms, the
Office of Population and Censuses should not
be deprived of resources. Dietary and other
carcinogenic factors certainly require more
interest and financial support. In the diag-
nostic section, the need for support for
programmes involved in early diagnosis was
emphasized.
In the sections on therapy, identification of
wrhy patients did better at specialist centres
needed explanation as soon as possible. The
use ofneutron therapy, particularly in gastric
carcinoma should be extended to early cases.
Adjuvant chemotherapy as the basis of con-
trolled clinical trials should bere-evaluated. It
wNias suggested that there should be 3 co-
ordinating groups for gastro-intestinal malig-
nant diseases: in gastric cancer, colo-rectal
cancer and lymphoma of the gastro-intestinal
tract.
Meetings suchasthisserve to highlight areas
of progress and lack of progress and are
invaluable at the national level for the
organization of clinical trials in these malig-
nant diseases.
H. BUSH
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